Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Riess

Showing results (161-170 of 313) with videos related to

Pageof 32
Sort By:
Frontiers in Behavioral Neuroscience|October 18, 2013
Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington diseaseAlexis Faure, Mouna Es-Seddiqi, Bruce L Brown, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 17, 2020
Psychosis-Like Behavior and Hyperdopaminergic Dysregulation in Human α-Synuclein BAC Transgenic RatsAlexia Polissidis, Maria Koronaiou, Vasia Kollia, et al.
European Journal of Human Genetics : EJHG|September 25, 2014
International Charter of principles for sharing bio-specimens and dataDeborah Mascalzoni, Edward S Dove, Yaffa Rubinstein, et al.
Frontiers in Molecular Neuroscience|June 5, 2023
Implications of specific lysine residues within ataxin-3 for the molecular pathogenesis of Machado-Joseph diseasePriscila Pereira Sena, Jonasz Jeremiasz Weber, Sercan Bayezit, et al.
Cellular and Molecular Life Sciences : CMLS|July 6, 2022
KPNB1 modulates the Machado-Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPPMahkameh Abeditashi, Jonasz Jeremiasz Weber, Priscila Pereira Sena, et al.
Brain : a Journal of Neurology|June 10, 2011
N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocationJeannette Hübener, Franz Vauti, Claudia Funke, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 13, 2007
Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidenceUlrike Bichelmeier, Thorsten Schmidt, Jeannette Hübener, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 30, 2010
Spinocerebellar ataxia type 11 (SCA11) is an uncommon cause of dominant ataxia among French and German kindredsPeter Bauer, Giovanni Stevanin, Christian Beetz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 17, 2011
Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington diseaseSophie Höhn, Glenn Dallérac, Alexis Faure, et al.
Plos One|February 27, 2015
Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington's disease is accompanied by striatal invasion of neuroblastsMahesh Kandasamy, Michael Rosskopf, Katrin Wagner, et al.
Pageof 32

Showing results (161-170 of 313) with videos related to

Sort By:
Pageof 32
Frontiers in Behavioral Neuroscience|October 18, 2013
Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington diseaseAlexis Faure, Mouna Es-Seddiqi, Bruce L Brown, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 17, 2020
Psychosis-Like Behavior and Hyperdopaminergic Dysregulation in Human α-Synuclein BAC Transgenic RatsAlexia Polissidis, Maria Koronaiou, Vasia Kollia, et al.
European Journal of Human Genetics : EJHG|September 25, 2014
International Charter of principles for sharing bio-specimens and dataDeborah Mascalzoni, Edward S Dove, Yaffa Rubinstein, et al.
Frontiers in Molecular Neuroscience|June 5, 2023
Implications of specific lysine residues within ataxin-3 for the molecular pathogenesis of Machado-Joseph diseasePriscila Pereira Sena, Jonasz Jeremiasz Weber, Sercan Bayezit, et al.
Cellular and Molecular Life Sciences : CMLS|July 6, 2022
KPNB1 modulates the Machado-Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPPMahkameh Abeditashi, Jonasz Jeremiasz Weber, Priscila Pereira Sena, et al.
Brain : a Journal of Neurology|June 10, 2011
N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocationJeannette Hübener, Franz Vauti, Claudia Funke, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 13, 2007
Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidenceUlrike Bichelmeier, Thorsten Schmidt, Jeannette Hübener, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 30, 2010
Spinocerebellar ataxia type 11 (SCA11) is an uncommon cause of dominant ataxia among French and German kindredsPeter Bauer, Giovanni Stevanin, Christian Beetz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 17, 2011
Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington diseaseSophie Höhn, Glenn Dallérac, Alexis Faure, et al.
Plos One|February 27, 2015
Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington's disease is accompanied by striatal invasion of neuroblastsMahesh Kandasamy, Michael Rosskopf, Katrin Wagner, et al.
Pageof 32